REGENERON PHARMACEUTICALS INC. - COMMON STOCK
718,47
05-февраля-25 14:42:05
15 мин. задержка
Акции
+21,42
+3,07%
Сегодняшний диапазон
700,01 - 729,25
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
NetDania - New 12 months High: REGENERON PHARMACEUTICALS INC. - COMMON STOCK
28 фев 2024 09:48:56 Источник NetDania Notify
-
NetDania - New 12 months High: REGENERON PHARMACEUTICALS INC. - COMMON STOCK
26 фев 2024 09:48:37 Источник NetDania Notify
-
NetDania - New 12 months High: REGENERON PHARMACEUTICALS INC. - COMMON STOCK
23 фев 2024 09:45:04 Источник NetDania Notify
-
23 фев 2024 01:00:00 Источник Nasdaq GlobeNewswire
-
21 фев 2024 07:00:13 Источник Nasdaq GlobeNewswire
-
Japan First in the World to Approve Dupixent® (dupilumab) for Chronic Spontaneous Urticaria (CSU)
16 фев 2024 00:59:00 Источник Nasdaq GlobeNewswire
-
Regeneron Announces Investor Conference Presentations
06 фев 2024 16:05:00 Источник Nasdaq GlobeNewswire
-
Regeneron Reports Fourth Quarter and Full Year 2023 Financial and Operating Results
02 фев 2024 06:30:01 Источник Nasdaq GlobeNewswire
-
Linvoseltamab Receives EMA Filing Acceptance for Treatment of Relapsed/Refractory Multiple Myeloma
02 фев 2024 06:00:04 Источник Nasdaq GlobeNewswire
-
30 янв 2024 07:00:41 Источник Nasdaq GlobeNewswire
-
25 янв 2024 14:29:00 Источник Nasdaq GlobeNewswire
-
24 янв 2024 12:00:00 Источник Nasdaq GlobeNewswire
-
16 янв 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
05 янв 2024 16:05:00 Источник Nasdaq GlobeNewswire
-
Regeneron Announces Presentation at the 42nd Annual J.P. Morgan Healthcare Conference
18 дек 2023 16:05:00 Источник Nasdaq GlobeNewswire
-
Regeneron Named on Dow Jones Sustainability World Index for Fifth Consecutive Year
11 дек 2023 07:30:00 Источник Nasdaq GlobeNewswire
-
10 дек 2023 19:30:00 Источник Nasdaq GlobeNewswire
-
10 дек 2023 12:30:00 Источник Nasdaq GlobeNewswire
-
07 дек 2023 07:00:45 Источник Nasdaq GlobeNewswire
-
Regeneron to Share Progress of Novel Combination Therapies in Oncology at ESMO IO
07 дек 2023 02:30:59 Источник Nasdaq GlobeNewswire